Show simple item record

dc.contributor.authorRoberts, SL
dc.contributor.authorZhang, He
dc.contributor.authorDee, G
dc.contributor.authorGray, B
dc.contributor.authorMindos, T
dc.contributor.authorParkinson, David
dc.date.accessioned2017-01-03T15:31:11Z
dc.date.available2017-01-03T15:31:11Z
dc.date.issued2017-01-13
dc.identifier.issn0022-3042
dc.identifier.issn1471-4159
dc.identifier.urihttp://hdl.handle.net/10026.1/8176
dc.description.abstract

<jats:title>Abstract</jats:title><jats:sec><jats:label /><jats:p>Myelination in the peripheral nervous system (<jats:styled-content style="fixed-case">PNS</jats:styled-content>) is controlled by both positive and negative regulators within Schwann cells to ensure timely onset and correct myelin thickness for saltatory conduction by neurons. Transcription factors such as Sox10, octamer‐binding transcription factor 6 (Oct6) and Krox20 form a positive regulatory network, whereas negative regulators such as <jats:styled-content style="fixed-case">cJ</jats:styled-content>un and Sox2 oppose myelination in Schwann cells. The role of the p38 <jats:styled-content style="fixed-case">MAPK</jats:styled-content> pathway has been studied in <jats:styled-content style="fixed-case">PNS</jats:styled-content> myelination, but its precise function remains unclear, with both positive and negative effects of p38 activity reported upon both myelination and processes of nerve repair. To clarify the role of p38 <jats:styled-content style="fixed-case">MAPK</jats:styled-content> in the <jats:styled-content style="fixed-case">PNS</jats:styled-content>, we have analysed mice with a Schwann cell‐specific ablation of the major p38 isoform, p38alpha. In line with previous findings of an inhibitory role for p38 <jats:styled-content style="fixed-case">MAPK</jats:styled-content>, we observe acceleration of post‐natal myelination in p38alpha null nerves, a delay in myelin down‐regulation following injury, together with a small increase in levels of re‐myelination following injury. Finally we explored roles for p38alpha in controlling axonal regeneration and functional repair following <jats:styled-content style="fixed-case">PNS</jats:styled-content> injury and observe that loss of p38alpha function in Schwann cells does not appear to affect these processes as previously reported. These studies therefore provide further proof for a role of p38 <jats:styled-content style="fixed-case">MAPK</jats:styled-content> signalling in the control of myelination by Schwann cells in the <jats:styled-content style="fixed-case">PNS</jats:styled-content>, but do not show an apparent role for signalling by this <jats:styled-content style="fixed-case">MAP</jats:styled-content> kinase in Schwann cells controlling other elements of Wallerian degeneration and functional repair following injury.</jats:p></jats:sec><jats:sec><jats:label /><jats:p> <jats:boxed-text content-type="graphic" position="anchor"><jats:graphic xmlns:xlink="http://www.w3.org/1999/xlink" mimetype="image/png" position="anchor" specific-use="enlarged-web-image" xlink:href="graphic/jnc13929-fig-0007-m.png"><jats:alt-text>image</jats:alt-text></jats:graphic></jats:boxed-text> </jats:p><jats:p><jats:bold>Cover Image</jats:bold> for this issue: doi: <jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1111/jnc.13793">10.1111/jnc.13793</jats:ext-link>.</jats:p></jats:sec>

dc.format.extent37-47
dc.format.mediumPrint-Electronic
dc.languageen
dc.language.isoen
dc.publisherWiley
dc.subjectmyelin
dc.subjectp38
dc.subjectperipheral nerve
dc.subjectregeneration
dc.subjectSchwann
dc.titleThe role of p38alpha in Schwann cells in regulating peripheral nerve myelination and repair
dc.typejournal-article
dc.typeJournal Article
dc.typeResearch Support, Non-U.S. Gov't
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000397502400004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue1
plymouth.volume141
plymouth.publication-statusPublished
plymouth.journalJournal of Neurochemistry
dc.identifier.doi10.1111/jnc.13929
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/Peninsula Medical School
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
plymouth.organisational-group/Plymouth/Users by role/Researchers in ResearchFish submission
dc.publisher.placeEngland
dcterms.dateAccepted2016-11-29
dc.rights.embargodate2018-1-13
dc.identifier.eissn1471-4159
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1111/jnc.13929
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2017-01-13
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV